Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History Study-Reference-Cited by-同舟云学术

Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History Study

Published:2016-04-15 Issue:4 Volume:11 Page:e0153461
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Boca Simina M.^ORCID,Nishida Maki,Harris Michael,Rao Shruti,Cheema Amrita K.,Gill Kirandeep,Seol Haeri,Morgenroth Lauren P.,Henricson Erik,McDonald Craig,Mah Jean K.,Clemens Paula R.,Hoffman Eric P.,Hathout Yetrib,Madhavan Subha

Funder

National Cancer Institute

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference39 articles.

1. Duchenne muscular dystrophy;G Danieli;Human genetics,1977

2. Population frequencies of inherited neuromuscular diseases—a world survey;AE Emery;Neuromuscular disorders,1991

3. A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy;JK Mah;Neuromuscular Disorders,2014

4. DMD Care Considerations Working Group: Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management;K Bushby;Lancet Neurol,2010

5. The cooperative international neuromuscular research group Duchenne natural history study—a longitudinal investigation in the era of glucocorticoid therapy: design of protocol and the methods used;CM McDonald;Muscle & nerve,2013

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of disease-specific alterations in metabolites and effects of mesenchymal stromal cells on dystrophic muscles;Frontiers in Cell and Developmental Biology;2024-06-14

2. Draft Guidance for Industry Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and Related Dystrophinopathies – Developing Potential Treatments for the Entire Spectrum of Disease;Journal of Neuromuscular Diseases;2024-03-05

3. Neuromuscular disorders in the omics era;Clinica Chimica Acta;2024-01

4. Biomarkers in Duchenne Muscular Dystrophy: Current Status and Future Directions;Journal of Neuromuscular Diseases;2023-11-07

5. Orthogonal proteomics methods warrant the development of Duchenne muscular dystrophy biomarkers;Clinical Proteomics;2023-06-12